Safety and Tolerance of Increased Doses of HRS-1780 Tablets in Healthy Subjects
NCT05638126
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
96
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Kidney Disease
Interventions
DRUG:
HRS-1780 table or placebo
DRUG:
HRS-1780 table or placebo
DRUG:
HRS-1780 table or placebo
Sponsor
Shandong Suncadia Medicine Co., Ltd.